Radiosensitizer AK-2123 enhances cytotoxic and cytostatic activity of splenocytes and macrophages in Lewis lung carcinoma bearing mice treated with cyclophosphamide

Experimental Oncology

Volumn 19, Issue 4, 1997, Pages 333-337

  Cherdyntseva, N V ^a   Kokorev, O V ^a   Konovalova, N P ^b   Kagiya, V T ^c  

^a CANCER RESEARCH INSTITUTE   (Russian Federation)

^b RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

^c Japan Radiosensitization Res Assoc   (Japan)

Author keywords

Cyclophosphamide; Immunocompetent cells; Lewis lung carcinoma; Nitrotriazol

Indexed keywords

CYCLOPHOSPHAMIDE; RADIOSENSITIZING AGENT; SENAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; IMMUNOMODULATION; LEWIS CARCINOMA; MACROPHAGE ACTIVATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; SPLEEN CELL;

EID: 0031468724     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Sakano K, Kimura R, Shibainoto Y et al. A nitrotriazole derivative, AK-2123 as a hypoxic cell sensitizer: neurotoxicity and pharmacokinetics. Radiosensitization Newsletter 1986; 5 (2): 1-2.
2. Kagiya VT. AK-2123 as a chemical modifier of cancer treatment. In: Proc 2nd Far-Eastern Int Symp "Multimodality Treatment of Cancer". Vladivostok, 1994: 50-1.
3. Ju QZ, Zhang J, Lin SZ. Effect of AK-2123 on the immune system in mice. Radiosensitization Newsletter 1986; 5 (1): 1-2.
4. Hester RV, Walker WS. Separation of murine mononuclear phagocytes by density gradients of per-coll. In: Methods for studying mononuclear phagocytes. New-York: Acad Press, 1981; 195-200.
5. Kuttan G, Kuttan R. Immunological mechanism of action of the tumor reducing peptide from mistletoe extract (NCS 635089) on cellular proliferation. Cancer Lett 1992; 66 (2): 123-30.
6. Konovalova NP, Diachkovskaya RF, Volkova LM. Anti-tumor effect of AK-2123 by ultra low dose daily administration in B-16 melanoma bearing mice. Sensitization Newslett 1996; 3 (2): 3-6.
7. Karashima A, Tanicushi K, Yoshikai Y, Nomoto K. Alteration in natural defence activity against NK-susceptible B-16 melanoma cells after treatment with Corynebacterium parvum. Immunology 1991; 182: 417-24.
8. Markovic S, Murasko D. Role of natural killer and T-cells in interferon-induced inhibition of spontaneous metastases of the B16F10L murine melanoma. Cancer Res 1991; 51: 1124-8.
9. Wallace P, Morahan P. Role of macrophages in the immunotherapy of Lewis lung peritoneal carcinomatosis. J Leuk Biol 1994; 56: 41-51.
10. Black P, Phillips H, Tribble H et al. Antitumor response to recombinant murine interferon-gamma correlates with enhanced immune function of organ-associated but not recirculating cytolytic T-lymphocytes and macrophages. Cancer Immunol Immunother 1993: 37: 299-306.
11. Oguri H, Sato Y, Sugawara H et al. The difference in immunological properties between lymph node metastatic and non-metastatic cell lines of MCA-induced fibrosarcoma of C4W mice. Tonoku J Exp Med 1992; 35: 409-12.